18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Recruiting
N/A
Interventional Study
Clear Cell Renal Cell Cancer (ccRCC)
Urothelial Carcinoma (UC)
Colorectal Cancer
Cervical Cancer
Ovarian Cancer
Head and Neck Cancer
Hepatocellular Carcinoma (HCC)
Cholangiocarcinoma
Non Small Cell Lung Cancer
Small Cell Lung Cancer
Breast Cancer
Pancreatic Cancer
Endometrial Cancer
Von Hippel Lindau Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 200 (estimated)
- Sponsor
- Peking University First Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate the diagnostic value of CAIX protein specific probe 18F-T2 in PET/CT imaging in participants with solid tumors. It will also assess the safety, tolerability and radiation dosimetry of 18F-T2.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
All participants must meet the following criteria:
1. Written and voluntarily given Informed Consent.
2. Male or female ≥18 years of age at time of consent.
3. Have the capacity to understand the study and be willing and able to comply with all protocol requirements.
4. Partici…
Contacts